1,518 results on '"Ozen, Seza"'
Search Results
2. Ocular Manifestations in Juvenile Behçet’s Disease: A Registry-Based Analysis from the AIDA Network
3. Acute kidney injury in children with moderate-severe COVID-19 and multisystem inflammatory syndrome in children: a referral center experience
4. Biologic drugs in the treatment of juvenile dermatomyositis: a literature review
5. Chronic non-bacterial osteomyelitis and immune checkpoint molecules
6. Possible Role of Dysbiosis of the Gut Microbiome in SLE
7. Treatment with Biologic Drugs in Pediatric Behçet’s Disease: A Comprehensive Analysis of the Published Data
8. The HyperPed-COVID international registry: Impact of age of onset, disease presentation and geographical distribution on the final outcome of MIS-C
9. Thrombotic manifestations in pediatric Behcet syndrome: A multicenter comparative study from the EUROFEVER registry
10. Treatment with Janus kinase inhibitors in juvenile dermatomyositis: A review of the literature
11. Pediatric Vasculitis
12. Dysregulation of miRNA-30e-3p targeting IL-1β in an international cohort of systemic autoinflammatory disease patients
13. Drug metabolism and inflammation related distinct miRNA signature of colchicine resistant familial Mediterranean fever patients
14. Clinical features, treatment and outcome of pediatric patients with severe cutaneous manifestations in IgA vasculitis: Multicenter international study
15. Childhood-onset Takayasu arteritis and immunodeficiency: case-based review
16. Biologics for immunoglobulin A vasculitis: targeting vasculitis or comorbid disease?
17. Distinct interferon signatures and cytokine patterns define additional systemic autoinflammatory diseases
18. Renal Vasculitis
19. Familial Mediterranean Fever: How to Interpret Genetic Results? How to Treat? A Quarter of a Century After the Association with the Mefv Gene
20. The performances of the ILAR, ASAS, and PRINTO classification criteria in ERA patients: a comparison study
21. Detection of genetic mutations underlying early-onset systemic lupus erythematosus
22. Risk for cancer development in familial Mediterranean fever and associated predisposing factors: an ambidirectional cohort study from the international AIDA Network registries
23. Defining criteria for disease activity states in systemic juvenile idiopathic arthritis based on the systemic Juvenile Arthritis Disease Activity Score
24. 5,6-dimethylxanthenone-4-acetic acid (DMXAA), a partial STING agonist, competes for human STING activation
25. Galantamine attenuates autoinflammation in a mouse model of familial mediterranean fever
26. The pyrin inflammasome aggravates inflammatory cell migration in patients with familial Mediterranean fever
27. The clinical course of SARS-CoV-2 infection among children with rheumatic disease under biologic therapy: a retrospective and multicenter study
28. Neurologic manifestations in children with COVID-19 from a tertiary center in Turkey and literature review
29. Comparison of IVIG resistance predictive models in Kawasaki disease
30. Impact of the COVID-19 pandemic on the frequency of the pediatric rheumatic diseases
31. Real-world data on MTX tolerance with regimens used in children versus adults
32. Drug-induced lupus erythematosus in childhood: Case-based review.
33. Characterization of serum extracellular vesicles and their differential level of miR-197-3p in familial Mediterranean fever patients.
34. Favipiravir use in children with COVID-19 and acute kidney injury: is it safe?
35. Hematopoietic Cell Transplantation Cures Adenosine Deaminase 2 Deficiency: Report on 30 Patients
36. Juvenile idiopathic arthritis: lymphocyte activation gene-3 is a central immune receptor in children with oligoarticular subtypes
37. The pyrin inflammasome, a leading actor in pediatric autoinflammatory diseases
38. Clinical spectrum of children with interstitial pneumonia with autoimmune features
39. Diversity in Serine/Threonine Protein Kinase-4 Deficiency and Review of the Literature
40. Familial Mediterranean Fever and Pyrin-Associated Autoinflammatory Syndromes
41. Behçet Disease
42. Comparison of EULAR/PRINTO/PReS Ankara 2008 and 2022 ACR/EULAR Classification Criteria for Granulomatosis with Polyangiitis in Children
43. 5,6-dimethylxanthenone-4-acetic acid (DMXAA), a Partial STING Agonist, Competes for Human STING Activation
44. Impact of serological activity on flare following clinically inactive disease and remission in childhood-onset systemic lupus erythematosus
45. Common genetic susceptibility loci link PFAPA syndrome, Behçet’s disease, and recurrent aphthous stomatitis
46. Multisystem inflammatory syndrome in children during the COVID-19 pandemic in Turkey: first report from the Eastern Mediterranean
47. Correction to: Hematopoietic Cell Transplantation Cures Adenosine Deaminase 2 Deficiency: Report on 30 Patients
48. Genetic disorders with symptoms mimicking rheumatologic diseases: A single-center retrospective study
49. Biological classification of childhood arthritis: roadmap to a molecular nomenclature
50. Performances of the “MS-score” And “HScore” in the diagnosis of macrophage activation syndrome in systemic juvenile idiopathic arthritis patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.